Page last updated: 2024-12-06

levanol fast cyanine 5rn

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Levanol Fast Cyanine 5RN: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18777
SCHEMBL ID15276051
MeSH IDM0065638

Synonyms (17)

Synonym
8-anilino-5-((4-((3-sulfophenyl)diazenyl)-1-naphthyl)diazenyl)-1-naphthalenesulfonic acid
8-anilino-5-[(e)-[4-[(e)-(3-sulfophenyl)azo]-1-naphthyl]azo]naphthalene-1-sulfonic acid
nsc47746
unii-75e2a9v57i
levanol fast cyanine 5rn
75e2a9v57i ,
einecs 246-448-2
8-(phenylamino)-5-((4-((3-sulphophenyl)azo)-1-naphthyl)azo)naphthalene-1-sulphonic acid
24758-50-7
8-(phenylamino)-5-[2-[4-[2-(3-sulfophenyl)diazenyl]-1-naphthalenyl]diazenyl]-1-naphthalenesulfonic acid
DTXSID3045069
SCHEMBL15276051
acid blue 113 free acid
1-naphthalenesulfonic acid, 8-(phenylamino)-5-((4-((3-sulfophenyl)azo)-1-naphthalenyl)azo)-
1-naphthalenesulfonic acid, 8-(phenylamino)-5-(2-(4-(2-(3-sulfophenyl)diazenyl)-1-naphthalenyl)diazenyl)-
levonol fast cyanine 5rn
Q27266374

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" As it had multiple functional groups from the raw materials, the amphoteric flocculant showed high color removal efficiency to anionic (acid blue 113, >95%), neutral (reactive black 5, >95%) and cationic dyes (methyl orange, >50%) in a wide range of flocculant dosage and pH windows."( Preparation of lignosulfonate-acrylamide-chitosan ternary graft copolymer and its flocculation performance.
He, K; Lou, T; Wang, X; Zhao, W, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (10.34)18.7374
1990's1 (3.45)18.2507
2000's4 (13.79)29.6817
2010's14 (48.28)24.3611
2020's7 (24.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.23%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]